Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Carnival reports a sharp rise in adjusted earnings for 2025 and improves leverage metrics, even as fuel costs and sec...
Exxon Mobil topped expectations in Q1 as LNG and Guyana projects accelerate. Investors are eyeing exxon mobil’s next ...
Analysts push higher targets for AMD as data center AI demand accelerates. A stock price prediction: strong consensus...
A pop culture moment becomes a practical finance lesson. Discover the money truths behind Carmen Electra’s reflection...
Gulf sovereign funds are expanding AI bets, backing SpaceX-linked ventures and major AI rounds, signaling a shift fro...
Benchmark analysts cheer Strategy’s pivot to STRC as the primary funding engine for bitcoin accumulation, signaling a...
As markets wobble in June 2026, investors weigh the true liquidity of stocks. This report explains why stocks are sti...
A bipartisan white paper proposes capping high Social Security payouts to extend the program’s solvency. The measure ...
OSL HK has listed USDKG, a gold-backed stablecoin issued by a state-supervised issuer, on its licensed exchange. The ...
AMD faces a pivotal test as the AI boom lifts data-center demand. Analysts debate whether it can become the next tril...
Apple filed a federal lawsuit alleging trade secret theft by former employees at OpenAI, threatening hardware know-ho...